These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1386055)

  • 1. Determination of hormonal response in uterine cancer cell lines by the ATP bioluminescence assay and flow cytometry.
    Nguyen HN; Sevin BU; Averette HE; Voigt W; Perras J; Angioli R; Ramos R; Donato D; Penalver M
    Gynecol Oncol; 1992 Jul; 46(1):55-61. PubMed ID: 1386055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Provera on chemotherapy of uterine cancer cell lines.
    Nguyen HN; Sevin BU; Averette HE; Perras J; Ramos R; Penalver M; Donato D
    Gynecol Oncol; 1991 Aug; 42(2):165-77. PubMed ID: 1832652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal modulation of radiation in uterine-cancer cell-lines.
    Nguyen H; Sevin B; Gottlieb C; Perras J; Averette H; Ramos R; Donato D; Penalver M
    Int J Oncol; 1993 Aug; 3(2):383-8. PubMed ID: 21573378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of ATP bioluminescence assay and flow cytometry in predicting radiosensitivity of uterine cancer cell lines: correlation of radiotoxicity and cell cycle kinetics.
    Nguyen HN; Sevin BU; Averette HE; Gottlieb CF; Perras J; Ramos R; Donato D; Penalver M
    Gynecol Oncol; 1992 Jul; 46(1):88-96. PubMed ID: 1634145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status.
    Ayoub J; Audet-Lapointe P; Méthot Y; Hanley J; Beaulieu R; Chemaly R; Cormier A; Déry JP; Drouin P; Gauthier P
    Gynecol Oncol; 1988 Oct; 31(2):327-37. PubMed ID: 2971597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptors and response of endometrial cancer to hormones in vitro.
    Grönroos M; Mäenpää J; Kangas L; Erkkola R; Paul R; Grenman S
    Ann Chir Gynaecol Suppl; 1987; 202():76-9. PubMed ID: 2959189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
    Carlson JA; Allegra JC; Day TG; Wittliff JL
    Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial carcinoma insensitive to progestin and cytotoxic chemotherapy may respond to tamoxifen.
    Kauppila A; Vihko R
    Acta Obstet Gynecol Scand; 1981; 60(6):589-90. PubMed ID: 6461159
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
    Billiet G; De Hertogh R; Bonte J; Ide P; Vlaemynck G
    Gynecol Oncol; 1982 Aug; 14(1):33-9. PubMed ID: 6212297
    [No Abstract]   [Full Text] [Related]  

  • 15. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
    Quinn MA; Cauchi M; Fortune D
    Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
    Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
    Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy.
    Runge HM; Teufel G; Neulen J; Geyer H; Pfleiderer A
    Cancer Chemother Pharmacol; 1986; 16(1):58-63. PubMed ID: 2933176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time.
    Noguchi S; Miyauchi K; Nishizawa Y; Koyama H
    Cancer; 1988 Apr; 61(7):1345-9. PubMed ID: 2964264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endometrial adenocarcinoma as a model for hormone-dependency and hormone-responsiveness of gynaecological cancers.
    Bonte J
    Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):335-41. PubMed ID: 6526120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of hormone therapy in metastasizing breast cancer].
    Samonigg H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.